BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 50 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,040 | -1.3% | 32,000 | 0.0% | 0.00% | – |
| Q2 2023 | $31,433 | -4.3% | 32,000 | 0.0% | 0.00% | – |
| Q1 2023 | $32,831 | -3.3% | 32,000 | 0.0% | 0.00% | – |
| Q4 2022 | $33,962 | +6.1% | 32,000 | 0.0% | 0.00% | – |
| Q3 2022 | $32,000 | 0.0% | 32,000 | 0.0% | 0.00% | – |
| Q2 2022 | $32,000 | 0.0% | 32,000 | 0.0% | 0.00% | – |
| Q1 2022 | $32,000 | -3.0% | 32,000 | 0.0% | 0.00% | – |
| Q4 2021 | $33,000 | 0.0% | 32,000 | 0.0% | 0.00% | – |
| Q3 2021 | $33,000 | 0.0% | 32,000 | 0.0% | 0.00% | – |
| Q2 2021 | $33,000 | +3.1% | 32,000 | 0.0% | 0.00% | – |
| Q1 2021 | $32,000 | -5.9% | 32,000 | 0.0% | 0.00% | – |
| Q4 2020 | $34,000 | – | 32,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 19,413,000 | $19,245,611 | 1.50% |
| SSI INVESTMENT MANAGEMENT LLC | 9,386,000 | $9,219,566 | 0.65% |
| PFM Health Sciences, LP | 15,000,000 | $14,771,520 | 0.57% |
| RWC Asset Management LLP | 11,000,000 | $10,848,475 | 0.52% |
| Sonora Investment Management Group, LLC | 6,280,000 | $6,184,858 | 0.52% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 24,020,000 | $23,654,128 | 0.46% |
| Lombard Odier Asset Management (Europe) Ltd | 7,224,000 | $7,124,489 | 0.34% |
| MACKAY SHIELDS LLC | 10,123,000 | $9,943,520 | 0.28% |
| PALISADE CAPITAL MANAGEMENT, LP | 9,478,000 | $9,323,983 | 0.25% |
| Nicholas Investment Partners, LP | 2,940,000 | $2,887,868 | 0.20% |